Overview of Current Regulatory Practices, Challenges and Guidance for Regulation of Stem Cells and Stem Cell Derived Products in India
Journal Title: Journal of Regenerative Biology and Medicine - Year 2019, Vol 1, Issue 1
Abstract
Stem Cell Science/Regenerative Medicine is perhaps the most important "pillar" out of the four pillars of modern medicine. Use and abuse of the "Stem Cells and Stem Cell derived Products" as therapeutic measure for treatment of several untreatable diseases has come to the fore in recent times. The "stem cells" are drugs as discussed below. In the realm of clinical trials, to be approved by FDA, just as a "drug" undergoes trials, successively via phase I, phase II and phase III trials, likewise stem cells, which are "drugs" per se has to be channeled through the same three phases of clinical trials. There are some evolving regulations in place for regulating stem cell research and its prospective human application in clinical trials which is in place, as per the guidelines of ICSSR 2016. Each and every country, including India has more or less similar rules and regulations which conform to the rules/regulations as proposed by ICSSR and followed by FDA, although many countries has done individual modifications in the same. The role of NAC-SCRT, ICMR, IEC, IC-SCR, DCGI are clearly defined and it has been clearly stated in NGSCR that approval for stem cell application in patients, (Autologous, allogenic, homologous or non-homologous) only within the confines of "clinical trials" and therapy based on Stem Cells and Stem Cell derived Products (SCDP) should be informed in a proper format to the regulatory concern and done through the proper channel. All laboratories and institutes coming under the umbrella of NGSCR should have GMP, GLP and GCP compliant. Appropriate clean room classification shall be followed for stem cell isolation, culturing or manipulation in their respective lab/institutes. The safety and efficacy concerns regarding animal and human applications, uniformity in batch production, strengthening of scientific knowhow should definitely be in line with the cutting edge technological advancements globally. Conformity with international guidelines, and peer reviewed publications are a must for getting approval for clinical trials and marketing options. The review as a whole may not be comprehensive enough to include all the points in relation to the regulatory domain for approving SCDP in our country but an attempt has been made to identify the important points keeping in mind that this domain will evolve and rules and regulations will change with the passage of time.
Authors and Affiliations
Yogesh Shelar1, M. P. Venkatesh1, C. Hemanth Kumar2, Manoj Bansode3, Kaniska Mukherjee4, Kaushik Deb4*
Keywords
Related Articles
- EP ID EP707299
- DOI https://doi.org/10.37191/Mapsci-2582-385X-1(1)-001
- Views 118
- Downloads 1
Aberfan: In memoriam
It was an ordinary day in Aberfan, Wales, and it ended in a disaster. On October 21, 1966, a 34-meter-high slag heap broke loose, slid down Mount Merthyr into the mining village and buried houses and an elementary school...
Antler Stem Cells Sustain Regenerative Wound Healing in Deer and in Rats
Deer antlers are unique mammalian appendages in that they can fully regenerate following loss from their pedicles (permanent bony protuberances). Antler regeneration starts from regenerative wound healing on top of a ped...
Overview of Current Regulatory Practices, Challenges and Guidance for Regulation of Stem Cells and Stem Cell Derived Products in India
Stem Cell Science/Regenerative Medicine is perhaps the most important "pillar" out of the four pillars of modern medicine. Use and abuse of the "Stem Cells and Stem Cell derived Products" as therapeutic measure for treat...
COVID-19: ACE-2 Receptor, TMPRSS2, Cathepsin-L/B and CD-147 Receptor
COVID-19 shows an extremely rapid spreading pattern, classified as SARS-CoV-2, has become a worldwide health problem. Relating to biological characteristics of SARS-CoV-2, the new viral agent was comprehensively summariz...
Anti-inflammatory and Antifibrotic Effects of Plant Regulatory Peptides in Patients with Steatohepatitis and Cirrhosis: Opportunities of Primary Liver Cancer Prevention
The pathogenesis of steatohepatitis, which develops on the background of non-alcoholic fatty liver disease and may be the cause of liver cirrhosis, is considered in the article. Also, the paper focuses on the prospects o...